LatestUIA Reports Significant Progress in Water Authority Classification and Pay Plan Negotiations
Cannabis

Rock Hill, Missouri Residents Sue Cannabis Facility Over Odor Complaints

TG Branfalt
Rock Hill, Missouri Residents Sue Cannabis Facility Over Odor Complaints
Summary

Residents of Rock Hill, Missouri are filing a lawsuit against New Growth Horizon's Proper Brands cannabis processing facility, alleging that noxious odors from the operation are causing property damage and nuisance. The complaint centers on the facility's emission of strong 'skunky' smells that allegedly invade neighboring properties. This case highlights ongoing tensions between cannabis industry operations and residential communities regarding environmental impacts and odor control measures. The lawsuit raises important questions about regulatory oversight and mitigation strategies for cannabis processing facilities operating near populated areas. Such disputes are becoming increasingly common as the legal cannabis market expands across the United States.

Originally published on

Ganjapreneur

By TG Branfalt

Read full article(opens in new tab)

Fetched: September 18, 2026 at 10:02 AM

Related News

More news you might be interested in

View all
High-Dose Oral THC Produces Psilocybin-Like Effects in Controlled Settings
Cannabis
AnxietyDepression

High-Dose Oral THC Produces Psilocybin-Like Effects in Controlled Settings

Researchers at Johns Hopkins University discovered that high doses of oral THC can produce experiences with characteristics similar to those induced by psilocybin when administered in a carefully designed psychedelic session format. This finding suggests that THC's potential therapeutic applications may extend beyond traditional cannabis use, particularly for conditions that could benefit from psychedelic-assisted therapy. The research highlights the importance of dosage, set, and setting in determining THC's psychological effects. These insights could inform future clinical protocols for mental health treatment and advance our understanding of how cannabinoids interact with consciousness and perception.

11 hours ago
Revista Cáñamo
First Data from Netherlands' Regulated Cannabis Program Shows Positive Results
Cannabis

First Data from Netherlands' Regulated Cannabis Program Shows Positive Results

The Netherlands' closed-chain cannabis regulation experiment has released its initial tracking data, revealing an expanded product supply, improved price-to-quality perception among consumers, and stable overall consumption patterns. This landmark study provides valuable insights into how regulated cannabis markets can function effectively while maintaining consumer safety and product standardization. The findings suggest that legal, controlled cannabis distribution systems may offer better value and variety compared to unregulated markets. These results are significant for jurisdictions like Puerto Rico considering medical cannabis regulation frameworks, demonstrating that structured oversight can balance accessibility with quality assurance. The data supports evidence-based policy development for therapeutic cannabis programs.

12 hours ago
Revista Cáñamo
Poll: Majority of Americans Don't Think Cannabis Use is Dangerous
Cannabis

Poll: Majority of Americans Don't Think Cannabis Use is Dangerous

A new Rasmussen Reports poll reveals shifting American attitudes toward cannabis safety, with 55% of respondents believing cannabis is not dangerous and only 37% perceiving it as harmful. Just 13% characterized cannabis as "very dangerous," indicating significantly reduced perceived risk compared to historical stigma. This data reflects evolving public opinion as more states implement medical cannabis programs and research expands on therapeutic applications. The findings suggest Americans increasingly distinguish between cannabis use and associated health risks, potentially influencing policy discussions around medical access and regulation.

13 hours ago
Ganjapreneur
Arizona Cannabis Chain Halts Products From Labs Cited for Inaccurate Testing
Cannabis

Arizona Cannabis Chain Halts Products From Labs Cited for Inaccurate Testing

Story Cannabis, a major Arizona dispensary chain, has announced it will no longer accept cannabis products tested by Kaycha Labs and Level One Labs after state regulators cited both laboratories for providing inaccurate testing results. This decision reflects growing concerns about quality assurance and testing integrity in the cannabis industry. Accurate cannabinoid potency and contaminant testing is critical for patients relying on medical cannabis for therapeutic purposes, as false claims about THC/CBD content or safety can compromise treatment efficacy and patient safety. The move highlights the importance of rigorous laboratory oversight and sets a standard for quality control that protects consumers.

14 hours ago
Ganjapreneur